Lipid-Based Nanocarriers for Enhanced Oral Bioavailability: A Review of Recent Advances and Applications
DOI:
https://doi.org/10.22270/ajprd.v13i1.1506Abstract
The development of innovative oral drug delivery systems is crucial for improving the bioavailability of poorly soluble drugs. This review focuses on lipid-based nanocarriers, including solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), and lipid-polymer hybrid nanoparticles (LPHNPs). These nanocarriers have shown promise in enhancing the solubility, permeability, and bioavailability of poorly soluble drugs. SLNs, NLCs, and LPHNPs have been designed to overcome the limitations of traditional oral drug delivery systems, offering improved stability, targeted delivery, and controlled release of drugs. The applications of these nanocarriers in cancer therapy, anti-inflammatory and analgesic drugs, antiviral and antibacterial agents, and cardiovascular and neurological disorders are also discussed. Despite the advantages of these nanocarriers, challenges such as stability, regulatory considerations, and scaling up production need to be addressed.
Downloads
References
Bhandare A and Nannor KM. Bioavailability in drug design and development: A comprehensive review. World Journal of Pharmaceutical Research 2024;13(17)145-168.
Zhang L, Wang S, Zhang M and Sun J. Nanocarriers for oral drug delivery. Journal of Drug Targeting 2013; 21(6): 515–527.
Preeti, Sambhakar S, Malik R, Bhatia S, Harrasi AA, Saharan R, Aggarwal G, Kumar S, Sehrawat R and Rani C. Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypertensive Agents. Hindawi International Journal of Hypertension 2024;1: 1-54.
Xu W, Ling P, and Zhang T. Polymeric Micelles, a Promising Drug Delivery System to Enhance Bioavailability of Poorly Water-Soluble Drugs. Hindawi Journal of Drug Delivery 2013;1:1-15.
Bagwan JA, Adhav DU, Ade DD, Bhalerao DD and Avdhut MS. A review on solid dispersion technique for enhancing solubility of poorly soluble drugs. World Journal of Pharmaceutical Research 2024;13(8):87-106.
Liu Y, Liang Y, Yuhong J, Xin P, Jia Li Han, Du Y, Yu X, Zhu R, Zhang M, Wen Chen & Yingjie Ma. Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs. Drug Design, Development and Therapy 2024;18:1469–1495.
Waheed I, Ali A, Tabassum H, Khatoon N, Wing-Fu Laiand Zhou X. Lipid-based nanoparticles as drug delivery carriers for cancer therapy. Frontiers in Oncology 2024;14:1296091.
Balmanno A, Falconer JR, Ravuri HG and Mills PC. Strategies to improve the Transdermal Delivery of Poorly Water-Soluble Non-Steroidal Anti-Inflammatory Drugs. Pharmaceutics 2024;16:675.
Anwar DM, Hedeya HY, Ghozlan SH, Ewas BM and Khattab SN. Surface-modified lipid-based nanocarriers as a pivotal delivery approach for cancer therapy: Application and recent advances in targeted cancer treatment. Beni-Suef Univ J Basic Appl Sci 2024;13:06.
Patel P, Garala K, Singh S, Prajapati BG and Chittasupho C. Lipid-Based Nanoparticles in Delivering Bioactive Compounds for Improving Therapeutic Efficacy. Pharmaceuticals 2024;17: 329.
Falke PB, Shelke PG, Hatwar PR, Bakal RL and Kohale NB. A comprehensive review on Nanoparticle: Characterization, classification, synthesis method, silver nanoparticles and its applications. GSC Biological and Pharmaceutical Sciences 2024;28(01):171–184.
Abbasi A, Hashemi M, Kafil HS, Astamal MA, Lahouty M, Tajani AG, Hosseini H, Nasirifar SZ. A Critical Review on the Bioavailability Promotion of the Food Bioactive Compounds: Nano Lipid Carriers Perspective. Pharmaceutical Sciences 2024;30(3):282-303.
Kesharwani R, Jaiswal P, Patel DK, Yadav PK. Lipid Based Drug Delivery System (LBDDS): An Emerging Paradigm to Enhance Oral Bioavailability of Poorly Soluble Drugs. Biomedical Materials & Devices 2022. https://doi.org/10.1007/s44174-022-00041-0
Mohammed HA, Khan RA, Singh V, Yusuf M, Akhtar N, Sulaiman GM, Albukhaty S, Abdellatif AH, Khan M, Mohammed SA, and Al-Subaiyel AM. Solid lipid nanoparticles for targeted natural and synthetic drugs delivery in high-incidence cancers, and other diseases: Roles of preparation methods, lipid composition, transitional stability, and release profiles in nanocarriers’ development. Nanotechnology Reviews 2023; 12:20220517.
Krishnan MN, Sangeetha S, Ranjani PS, Narayanasamy D. The Science of Solid Lipid Nanoparticles: From Fundamentals to Applications. Cureus 2024; 16(9): e68807.
Phalak S, Bodke V, Yadav R, Pandav S, Ranaware M. A systematic review on nano drug delivery system: solid lipid nanoparticles (SLN).International Journal of Current Pharmaceutical Research 2024;16(1):10-20.
Harde H, Das M and Jain S. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin. Drug Deliv. 2011; 8(11):1407-1424.
Duan Y, Dhar A, Patel C, Khimani M, Neogi S, Sharma P, Kumar NS and Vekariya RL, A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems. RSC Adv., 2020; 10: 26777–26791.
Munir M, Zaman M, Waqar MA, Khan MA & Alvi MN. Solid lipid nanoparticles: a versatile approach for controlled release and targeted drug delivery. Journal of Liposome Research 2024;34(2):335-348.
Arabestani MR, Bigham A, Kamarehei F, Dini M, Gorjikhah F, Shariati A, Hosseini SM. Solid lipid nanoparticles and their application in the treatment of bacterial infectious diseases. Biomedicine & Pharmacotherapy 2024; 174:116433.
Eker F, Duman H, Akda E, Bolat E, Sarıta S, Karav S and Witkowska MA. A Comprehensive Review of Nanoparticles: From Classification to Application and Toxicity. Molecules 2024; 29:3482.
Khan S, Sharma A, Jain V. An overview of Nanostructured Lipid Carriers and its application in drug delivery through different routes. Adv Pharm Bull. 2023 Jul;13(3):446-460. doi: 10.34172/apb.2023.056. Epub 2022 Sep 18. PMID: 37646052; PMCID: PMC10460807.
D. Pranitha, Velraj M. Advancing oral drug bioavailability: A comprehensive review of Nanostructured Lipid Carriers. International Journal of Chemical and Biochemical Sciences 2023;24(12):96-103.
Godase SS, Kulkarni NS, Dhole SN. A Comprehensive Review on Novel Lipid-Based Nano Drug Delivery. Adv Pharm Bull 2024;14(1):34-47.
Wathoni N, Suhandi C, Elamin KM, Lesmana R, Hasan N, Mohammed AFA, Ali El-Rayyes and Wilar G. Advancements and Challenges of Nanostructured Lipid Carriers for Wound Healing Applications. International Journal of Nanomedicine 2024;19: 8091–8113.
Fitriani EW, Avanti C, Rosana Y, Surini S. Nanostructured lipid carriers: A prospective dermal drug delivery system for natural active ingredients. Pharmacia 2024; 71:1–15.
Mishra R, Devi. Solid dispersion: An overview of different methodology and techniques. International Journal of Research and Analytical Reviews 2024; 11(1):392-400.
Albakr L, Hongyuan Du, Zhang X, Kathuria H, Anwar-Fadzil AF, Wheate NJ, and Kang L. Progress in Lipid and Inorganic Nanocarriers for Enhanced Skin Drug Delivery. Adv. Nano Biomed Res. 2024;4: 2400003.
Chaudhary AA, Fareed M, Salah-Ud-Din Khan, Lina M. Alneghery LM, Aslam M, Arockia Alex, Md. Rizwanullah. Exploring the therapeutic potential of lipid-based nanoparticles in the management of oral squamous cell carcinoma. Explor Target Antitumor Ther. 2024; 5:1223– 46.
Dhayalan M, Wang W, S. U. Mohammed Riyaz, Dinesh RA Shanmugam J, Irudayaraj SS, Stalin A, Giri J, Mallik S, Ruifeng Hu. Advances in functional lipid nanoparticles: From drug delivery platforms to clinical applications. 3 Biotech 2024; 14:57.
Zhang T. Applications of Lipid Nanoparticles in CRISPR Technology. Dean & Francis. 2024; 1(7):1-5.
Nasikkar Z, Tiwari S, Vishwakarma R, Tarmale P, Verma N and Turerao M. Solid dispersion: A review. World Journal of Pharmaceutical Research 2024; 13(9) 271-287.
Sajjadi S, Shayanfar A, Kiafar F, Siahi-Shadbad M, Tacrolimus: Physicochemical stability challenges, analytical methods, and new formulations. International Journal of Pharmaceutics: X 2024; 8:100285.
Motwani A, Hatwar PR, Dr. Bakal RL. Advances in Solubility Enhancement of Poorly Soluble Drugs in Pharmaceutical Development: A Review of Current Techniques and Strategies. International journal of pharmaceutical sciences. 2024; 2(11):138-148.
Anjum S, Hashim M, Malik SA, Khan M, Lorenzo JM, Abbasi BH and Hano C. Recent Advances in Zinc Oxide Nanoparticles (ZnO NPs) for cancer diagnosis, target drug delivery, and treatment. Cancers 2021; 13:4570.
Fatima A, Naseem N, Md Haider F, Md Rahman A, Mall J, Saifi MS, Akhtar J. A comprehensive review on nanocarriers as a targeted delivery system for the treatment of breast cancer. Intelligent Pharmacy 2024; 2(3):415–426.
Alharbi HM. Exploring the Frontier of Biopolymer-Assisted Drug Delivery: Advancements, Clinical Applications, and Future Perspectives in Cancer Nanomedicine. Drug Design, Development and Therapy 2024; 18:2063–2087.
Sokołowska P, Bleibel L, Owczarek J, Wiktorowska-Owczarek A. PPARγ, NF-κB and the UPR pathway as new molecular targets in the anti-inflammatory actions of NSAIDs: Novel applications in cancers and central nervous system diseases? Advances in Clinical and Experimental Medicine.2024:1899–5276.
Kim SH, Keum B, Kwak S, Byun J, Shin JM, and Kim TH Therapeutic Applications of Extracellular Vesicles in Inflammatory Bowel Disease. Int. J. Mol. Sci. 2024; 25:745.
Omidian H, Gill EJ and Cubeddu LX. Lipid Nanoparticles in Lung Cancer Therapy. Pharmaceutics. 2024; 16:644.
Chakraborty SS, Panja A, Dutta S, Patra P. Advancements in nanoparticles for skin care: a comprehensive review of properties, applications, and future perspectives. Discover Materials 2024; 4:17.
Singh K, Bhushan B, Chanchal DK, Sharma SK, Rani K, Yadav MK, Porwal P, Kumar S, Sharma A, Virmani T, Kumar G and Noman A. Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review. Hindawi Behavioural Neurology 2023; 1:1-17.
Sisodiya D, Madhavilatha B, Bandigari P, Katual KM, Gupta N, Krosuri P, Vishvakarma P, Negi SS. Bacterial Nanocarriers for Site-Specific Drug Delivery: Harnessing Microorganisms for Precision Medicine. African Journal of Biological Sciences 2024; 6(9);2400-2420.
Anita A, Jain T, Saini C, Devi N, Boora N, Kandukuri KM, Lal S and Aggarwal D. Enhanced delivery of herbal medications by using Ethosomes. Enhanced delivery of herbal medications by using ethosomes 2024; 24(1):541-552.
Zhuo Y, Zhao YG and Zhang Y. Enhancing Drug Solubility, Bioavailability, and Targeted Therapeutic Applications through Magnetic Nanoparticles. Molecules 2024; 29:4854.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Aboli P. Mangle, Dr. Ravindra L, Pooja R. Hatwar, Jitendra A. Kubde
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.